Callan Capital, LLC Connect Biopharma Holdings LTD Transaction History

Callan Capital, LLC

  • $1.35 Billion
  • Q1 2025

A detailed history of Callan Capital, LLC transactions in Connect Biopharma Holdings LTD stock. As of the latest transaction made, Callan Capital, LLC holds 80,000 shares of CNTB stock, worth $167,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares
80,000
Previous 80,000 -0.0%
Holding current value
$167,200
Previous $96,000 54.17%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 03, 2025
BUY
$0.95 - $1.52 $36,268 - $58,029
38,177 Added 91.28%
80,000 $96,000
Q3 2024

Nov 12, 2024
BUY
$0.99 - $1.6 $41,404 - $66,916
41,823 New
41,823 $60,000

Others Institutions Holding CNTB

# of Institutions
4
Shares Held
185K
Call Options Held
0
Put Options Held
0
View Full List

About Connect Biopharma Holdings Ltd

CNTB Quotes by TradingView
  • Ticker CNTB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,015,800
  • Market Cap $115M
  • Description
  • Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...
More about CNTB
Track This Portfolio

Track Callan Capital, LLC Portfolio

Follow Callan Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Callan Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Callan Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email